COVID-19: WHO Resumes Hydroxychloroquine Trials

The World Health Organisation (WHO) has resumed clinical trial on hydrochloroquine after it paused research on the drug for the treatment of COVID-19 last week.

Announcing this during a media briefing Wednesday, the Director General, WHO, Dr. Terdos Ghebreyesus, said new information has suggested that there was no reason to modify the trial protocol hence the continuation of the research.

He said: “As you know, last week the Executive Group of the Solidarity Trial decided to implement a temporary pause of the hydroxychloroquine arm of the trial, because of concerns raised about the safety of the drug.

“This decision was taken as a precaution while the safety data were reviewed. The Data Safety and Monitoring Committee of the Solidarity Trial has been reviewing the data. On the basis of the available mortality data, the members of the committee recommended that there are no reasons to modify the trial protocol.

Comments

Popular posts from this blog

Photos of scantily-clad Zulu virgins at the ongoing annual Reed Dance

Play up Nigeria’s positive values, Buhari tells Ambassadors-designate